In October 2020, you wrote the following in Policy Options:
[W]e have given less thought to a key policy that could build redundancy in our critical drug supply and even create...well-paying jobs for that much needed COVID-19 economic recovery: manufacturing drugs in Canada. Until we domestically produce select, critical medications (and their precursors), we will not be able to secure our drug supply and will be left at the mercy of other countries when the future waves of the pandemic arrive.
Could you please outline for us why domestic manufacturing is necessary to ensure pharmaceutical security in Canada?